Clinical Trial Update: Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating synbiotics and fecal microbiota transplantation for non-alcoholic steatohepatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)
• Synbiotics

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease | Phase 2 | Status: RECRUITING